Featured Research

from universities, journals, and other organizations

'Orphan' sleep drug may be potent cancer-fighting agent

Date:
May 21, 2012
Source:
Fred Hutchinson Cancer Research Center
Summary:
An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study. The novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more effective cancer therapies.

An inexpensive "orphan drug" used to treat sleep disorders appears to be a potent inhibitor of cancer cells, according to a new study led by scientists at Fred Hutchinson Cancer Research Center. Their novel approach, using groundbreaking technology that allows rapid analysis of the genome, has broad implications for the development of safer, more-effective cancer therapies.

The findings are published in the May 21 issue of the Proceedings of the National Academy of Sciences.

A research team led by corresponding author Carla Grandori, M.D., Ph.D., an investigator in the Hutchinson Center's Human Biology Division, used a high-speed robotic technology called high-throughput screening and a powerful genetic technique called siRNA gene silencing to uncover fatal weaknesses in cancer cells driven by an oncogene known as "Myc," which is hyperactive in many cancers, including those of the brain, breast, lung, ovary and liver.

Myc traditionally has been considered an "undruggable" oncogene because it is not readily neutralized by the kind of small, stable molecule that would work as a cancer drug. Even if such drugs existed, they would likely disable Myc in normal cells as well, which would create toxic side effects.

"Fortunately, Myc-driven cancer cells have an Achilles heel," Grandori said. "Their rapid growth and division damages their DNA, and they rely on other genes to repair that damage. Disabling those genes can cripple the cancer's ability to grow."

Grandori and colleagues found more than 100 genes which, when blocked, caused the death of Myc-driven cancer cells but not normal cells. This suggests that each of these genes is a potential target for a new, nontoxic cancer therapy.

One of these genes, CSNK 1 epsilon, is especially promising. Not only does silencing it kill cancer while sparing normal tissue, but an inhibitor for the enzyme it produces already exists: a compound that originally was developed to modulate sleep cycles.

"It had been sitting on a shelf for years, like the thousands of other 'orphan' drugs that are abandoned when they prove ineffective for their intended use," Grandori said.

With a simple, five-minute web search, she purchased the compound online and designed an experiment to test its potential.

She implanted special laboratory mice with Myc-driven neuroblastomas (a deadly cancer of the nervous system that often strikes children), and treated half of them with the new compound. The untreated mice quickly died of their tumors, but the treated mice thrived and their neuroblastomas shrank away.

"It is possible that the next great breakthrough in cancer therapy is already out there, sitting on a shelf, hiding in plain view," said Grandori, who is also a research associate professor and director of the Quellos High Throughput Screening Core at the University of Washington Department of Pharmacology.

Grandori feels that the combination of high-throughput screening and siRNA silencing has the potential to radically change the way cancers are treated.

"We've barely scratched the surface," she said. "These techniques are incredibly powerful, but they're new and not widely known. There are thousands of researchers who could apply this approach to their work. In the right hands, it could speed up the development of new cancer therapies a thousand-fold."


Story Source:

The above story is based on materials provided by Fred Hutchinson Cancer Research Center. Note: Materials may be edited for content and length.


Journal Reference:

  1. Masafumi Toyoshima, Heather L. Howie, Maki Imakura, Ryan M. Walsh, James E. Annis, Aaron N. Chang, Jason Frazier, B. Nelson Chau, Andrey Loboda, Peter S. Linsley, Michele A. Cleary, Julie R. Park, and Carla Grandori. Functional genomics identifies therapeutic targets for MYC-driven cancer. PNAS, May 23, 2012 DOI: 10.1073/pnas.1121119109

Cite This Page:

Fred Hutchinson Cancer Research Center. "'Orphan' sleep drug may be potent cancer-fighting agent." ScienceDaily. ScienceDaily, 21 May 2012. <www.sciencedaily.com/releases/2012/05/120521163747.htm>.
Fred Hutchinson Cancer Research Center. (2012, May 21). 'Orphan' sleep drug may be potent cancer-fighting agent. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2012/05/120521163747.htm
Fred Hutchinson Cancer Research Center. "'Orphan' sleep drug may be potent cancer-fighting agent." ScienceDaily. www.sciencedaily.com/releases/2012/05/120521163747.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Pregnancy Spacing Could Have Big Impact On Autism Risks

Pregnancy Spacing Could Have Big Impact On Autism Risks

Newsy (Oct. 1, 2014) A new study says children born less than one year and more than five years after a sibling can have an increased risk for autism. Video provided by Newsy
Powered by NewsLook.com
Robotic Hair Restoration

Robotic Hair Restoration

Ivanhoe (Oct. 1, 2014) A new robotic procedure is changing the way we transplant hair. The ARTAS robot leaves no linear scarring and provides more natural results. Video provided by Ivanhoe
Powered by NewsLook.com
Insertable Cardiac Monitor

Insertable Cardiac Monitor

Ivanhoe (Oct. 1, 2014) A heart monitor the size of a paperclip that can save your life. The “Reveal Linq” allows a doctor to monitor patients with A-Fib on a continuous basis for up to 3 years! Video provided by Ivanhoe
Powered by NewsLook.com
Attacking Superbugs

Attacking Superbugs

Ivanhoe (Oct. 1, 2014) Two weapons hospitals can use to attack superbugs. Scientists in Ireland created a new gel resistant to superbugs, and a robot that can disinfect a room in minutes. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins